How Oncotarget is making a Change in Scientific Research Through Peer-Review

Oncotarget is one of the most influential medical journals of the 21st century. Their primary focus is publishing articles and research findings on topics related to oncology. However, they have recently expanded their reach and are accepting publications in topics related to Neuroscience, Endocrinology, Cardiology, Metabolism, Cell Biology, Pharmacology, and many other areas.

The journal plays a very instrumental role mainly because the better part of the 20th Century and the beginning of the 21st century has been spent looking for therapies and cures for cancer and other life-threatening conditions. Governments have increased funding into scientific research and scientists are looking more deeply into stem cell research. Oncotarget believes that making scientific study results will be one of the most efficient ways to promote better scientific research. Follow Oncotarget on Twitter.

The papers published on Oncotarget are made available online on weekly issues, and in case one has a particular demand, they can have the documents printed. The move has helped the community of science to have free access to exceptional discoveries in science. As a result, another scientist can build on the already made discoveries to advance scientific research and solve problems that are still affecting clinical research. The success of the publication has been attributed to among other things, the presence of a sound and experienced team leading the editing and publishing of the journal.

It is the success they have had with oncology that has motivated the journal to expand their reach into other areas of scientific research. They are hoping that they will make an even greater impact on the community with the new move. The leadership of the magazine includes Andrei V. Gudkov and Mikhail Blagosklonny, who are the editors in chief. The two are renowned scientists working with the Roswell Park Cancer Institute. Other members of the Editorial Board include Frederick Alt of the Harvard Medical School, Carlo M. Croce from the Ohio State University and Arthur B. Pardee of the Harvard Medical School.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/

The team hopes that they will manage to do even more to advance scientific research and consequently solve most of the medical problems facing humanity in the 21st century.

Leave a Reply